NO961547L - Flavin derivatives as anti-viral agents - Google Patents
Flavin derivatives as anti-viral agentsInfo
- Publication number
- NO961547L NO961547L NO961547A NO961547A NO961547L NO 961547 L NO961547 L NO 961547L NO 961547 A NO961547 A NO 961547A NO 961547 A NO961547 A NO 961547A NO 961547 L NO961547 L NO 961547L
- Authority
- NO
- Norway
- Prior art keywords
- viral agents
- flavin derivatives
- derivatives
- flavin
- riboflavin
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Forskjellige flavinderivat er avdekket til medisinering av pattedyr som et middel mot virus. Riboflavin og riboflavinderivat er gitt som særlige eksempler som kan bli foretrukket.Various flavin derivatives have been revealed for the administration of mammals as a remedy for viruses. Riboflavin and riboflavin derivatives are given as particular examples which may be preferred.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB939321558A GB9321558D0 (en) | 1993-10-19 | 1993-10-19 | Anti-viral agents |
PCT/GB1994/002292 WO1995011028A1 (en) | 1993-10-19 | 1994-10-19 | Flavin derivatives as anti-viral agents |
Publications (2)
Publication Number | Publication Date |
---|---|
NO961547D0 NO961547D0 (en) | 1996-04-18 |
NO961547L true NO961547L (en) | 1996-06-19 |
Family
ID=10743784
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO961547A NO961547L (en) | 1993-10-19 | 1996-04-18 | Flavin derivatives as anti-viral agents |
Country Status (26)
Country | Link |
---|---|
EP (1) | EP0739208A1 (en) |
JP (1) | JPH09505804A (en) |
CN (1) | CN1140992A (en) |
AP (1) | AP620A (en) |
AU (1) | AU7943794A (en) |
BG (1) | BG100599A (en) |
BR (1) | BR9407862A (en) |
CA (2) | CA2123825A1 (en) |
CO (1) | CO4520283A1 (en) |
CZ (1) | CZ113796A3 (en) |
EE (1) | EE9600057A (en) |
GB (2) | GB9321558D0 (en) |
HR (1) | HRP940688A2 (en) |
HU (1) | HUT76322A (en) |
IL (1) | IL111338A0 (en) |
JO (1) | JO1866B1 (en) |
MA (1) | MA23356A1 (en) |
MD (1) | MD960168A (en) |
NO (1) | NO961547L (en) |
OA (1) | OA10579A (en) |
PE (1) | PE5596A1 (en) |
PL (1) | PL314008A1 (en) |
SK (1) | SK50696A3 (en) |
UY (1) | UY23844A1 (en) |
WO (1) | WO1995011028A1 (en) |
ZA (1) | ZA948191B (en) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH07188052A (en) * | 1993-12-27 | 1995-07-25 | Sanwa Kagaku Kenkyusho Co Ltd | Interferon activity-enhancing agent and antivirus activity-enhancing composition containing the enhancing agent and interferon |
US5756479A (en) * | 1994-12-29 | 1998-05-26 | Research Development Foundation | Flavin adenine dinucleotide analogue inhibitors of monoamine oxidase |
US9044523B2 (en) | 2000-06-15 | 2015-06-02 | Terumo Bct, Inc. | Reduction of contaminants in blood and blood products using photosensitizers and peak wavelengths of light |
US6933285B2 (en) * | 2002-05-10 | 2005-08-23 | The Ohio State University | Flavin N-oxides: new anti-cancer agents and pathogen eradication agents |
ITTO20020622A1 (en) | 2002-07-16 | 2004-01-16 | Dayco Europe Srl | INTEGRATED PULLEY-TORSIONAL DAMPER GROUP |
US20060293335A1 (en) * | 2002-08-02 | 2006-12-28 | Qishou Xu | Riboflavin derivative and its manufacture and uses |
EP2545788A1 (en) * | 2011-07-13 | 2013-01-16 | Martin Hulliger | Dietary multi-component system |
JP2018131410A (en) * | 2017-02-15 | 2018-08-23 | ヒノキ新薬株式会社 | Caspase-3 inhibitor and use thereof |
US11497749B2 (en) * | 2017-10-24 | 2022-11-15 | Lunella Biotech, Inc. | Mitoflavoscins: targeting flavin-containing enzymes eliminates cancer stem cells (CSCS) by inhibiting mitochondrial respiration |
CN114126603A (en) * | 2019-07-09 | 2022-03-01 | 帝斯曼知识产权资产管理有限公司 | Reduction of viral activity of elaverde with riboflavin or DHA |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4219545A (en) * | 1979-03-23 | 1980-08-26 | Collins Calvin E | Treatment of infectious keratoconjunctivitis in animals |
US4264601A (en) * | 1979-06-12 | 1981-04-28 | The Board Of Regents Of The University Of Oklahoma | Antihypertensive agents and their use in treatment of hypertension |
US4500524A (en) * | 1982-09-15 | 1985-02-19 | Trustees Of Boston University | Tranquilizing and reducing or preventing seizures |
WO1991002529A2 (en) * | 1989-08-14 | 1991-03-07 | John Bennett Kizer | Product and method for killing abnormal vertebrate cells |
JP2727471B2 (en) * | 1989-09-14 | 1998-03-11 | 三井農林株式会社 | Influenza virus infection prevention agent |
US5192264A (en) * | 1989-10-06 | 1993-03-09 | The Beth Israel Hospital Association | Methods and apparatus for treating disease states using oxidized lipoproteins |
US5217716A (en) * | 1990-07-18 | 1993-06-08 | The Beth Israel Hospital Association | Method for treating viral infections using oxidized lipoproteins |
FR2674753B1 (en) * | 1991-04-02 | 1995-03-10 | Jean Berque | NEW THERAPEUTIC INDICATIONS, PARTICULARLY FOR THE TREATMENT OF AIDS, OF AN ALREADY EXISTING MEDICINAL PRODUCT FROM A DENIMOUS MOLECULE OF CONTRAINDICATIONS AND ADVERSE REACTIONS. |
NZ244270A (en) * | 1991-09-13 | 1995-07-26 | Eisai Co Ltd | Injectable composition comprising riboflavin |
WO1993010784A1 (en) * | 1991-11-25 | 1993-06-10 | University Of Michigan | Therapeutic composition and method for preventing reperfusion injury |
JP3073309B2 (en) * | 1992-03-27 | 2000-08-07 | 雪印乳業株式会社 | Sialic acid-bound 5-deazaflavin compounds |
-
1993
- 1993-10-19 GB GB939321558A patent/GB9321558D0/en active Pending
-
1994
- 1994-01-19 JO JO19941866A patent/JO1866B1/en active
- 1994-05-18 CA CA2123825A patent/CA2123825A1/en active Pending
- 1994-10-18 MA MA23679A patent/MA23356A1/en unknown
- 1994-10-19 GB GB9421099A patent/GB2283913A/en not_active Withdrawn
- 1994-10-19 CO CO94047671A patent/CO4520283A1/en unknown
- 1994-10-19 PE PE1994253128A patent/PE5596A1/en not_active Application Discontinuation
- 1994-10-19 HR HR9321558.0A patent/HRP940688A2/en not_active Application Discontinuation
- 1994-10-19 AP APAP/P/1994/000695A patent/AP620A/en active
- 1994-10-19 WO PCT/GB1994/002292 patent/WO1995011028A1/en not_active Application Discontinuation
- 1994-10-19 HU HU9601006A patent/HUT76322A/en unknown
- 1994-10-19 EP EP94930272A patent/EP0739208A1/en not_active Withdrawn
- 1994-10-19 BR BR9407862A patent/BR9407862A/en not_active Application Discontinuation
- 1994-10-19 PL PL94314008A patent/PL314008A1/en unknown
- 1994-10-19 ZA ZA948191A patent/ZA948191B/en unknown
- 1994-10-19 IL IL11133894A patent/IL111338A0/en unknown
- 1994-10-19 JP JP7511518A patent/JPH09505804A/en active Pending
- 1994-10-19 UY UY23844A patent/UY23844A1/en unknown
- 1994-10-19 CZ CZ961137A patent/CZ113796A3/en unknown
- 1994-10-19 EE EE9600057A patent/EE9600057A/en unknown
- 1994-10-19 CN CN94194350A patent/CN1140992A/en active Pending
- 1994-10-19 CA CA002174552A patent/CA2174552A1/en not_active Abandoned
- 1994-10-19 SK SK506-96A patent/SK50696A3/en unknown
- 1994-10-19 AU AU79437/94A patent/AU7943794A/en not_active Abandoned
-
1996
- 1996-04-18 NO NO961547A patent/NO961547L/en unknown
- 1996-04-18 OA OA60815A patent/OA10579A/en unknown
- 1996-05-17 BG BG100599A patent/BG100599A/en unknown
- 1996-05-17 MD MD96-0168A patent/MD960168A/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CN1140992A (en) | 1997-01-22 |
MD960168A (en) | 1998-04-30 |
HUT76322A (en) | 1997-08-28 |
HU9601006D0 (en) | 1996-06-28 |
NO961547D0 (en) | 1996-04-18 |
EE9600057A (en) | 1996-10-15 |
PE5596A1 (en) | 1996-04-18 |
GB9421099D0 (en) | 1994-12-07 |
IL111338A0 (en) | 1994-12-29 |
EP0739208A1 (en) | 1996-10-30 |
AP620A (en) | 1997-10-14 |
SK50696A3 (en) | 1997-01-08 |
CA2174552A1 (en) | 1995-04-27 |
CO4520283A1 (en) | 1997-10-15 |
BR9407862A (en) | 1997-05-20 |
GB9321558D0 (en) | 1993-12-08 |
ZA948191B (en) | 1995-06-08 |
CZ113796A3 (en) | 1996-11-13 |
BG100599A (en) | 1997-02-28 |
JO1866B1 (en) | 1995-12-27 |
HRP940688A2 (en) | 1997-04-30 |
UY23844A1 (en) | 1995-03-28 |
PL314008A1 (en) | 1996-08-05 |
AU7943794A (en) | 1995-05-08 |
JPH09505804A (en) | 1997-06-10 |
GB2283913A (en) | 1995-05-24 |
AP9400695A0 (en) | 1995-01-31 |
CA2123825A1 (en) | 1995-04-20 |
WO1995011028A1 (en) | 1995-04-27 |
OA10579A (en) | 2002-06-19 |
MA23356A1 (en) | 1995-07-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20034094D0 (en) | Compositions comprising an anti-diarrheal agent and an epothilone or epothilone derivative | |
MY107843A (en) | Anti-viral compounds. | |
ES2051641A1 (en) | Compounds and methods for inhibition of HIV and related viruses. | |
FI891716A (en) | HIV PROTEASIN INHIBITOR, SOM AER ANVAENDBARA VID BEHANDLING AV AIDS. | |
NO961547L (en) | Flavin derivatives as anti-viral agents | |
DK0711158T3 (en) | Method of treating atherosclerosis or restenosis using microtubule stabilizer | |
NO304374B1 (en) | 1-Benzenesulfonyl-1,3-dihydro-2H-benzimidazol-2-one derivatives, and pharmaceutical compositions containing them | |
DK0574457T3 (en) | Antiviral nucleoside combination | |
HUP9904092A2 (en) | Pharmaceutical composition for treatment hiv and cancer and process for producing it | |
DK1126867T3 (en) | Composition for the prevention and / or treatment of atherosclerosis | |
AU3627289A (en) | Pharmaceutical products | |
IT9019324A0 (en) | DERIVATIVES OF BILOBALIDE, THEIR USES AND FORMULATIONS THAT CONTAIN THEM | |
MX9201847A (en) | HETEROCICLIC DERIVATIVES OF ANTISEROTONINS, PROCEDURE FOR THE PREPARATION AND MEDICINES THAT CONTAIN THEM. | |
AU4445089A (en) | Lactamimides in the treatment of drug-resistant protozoal infections | |
AU641279B2 (en) | Oligosaccharide derivatives | |
AU2861389A (en) | Disubstituted pyridines | |
NO954702L (en) | Aryl forming drugs | |
NO975636L (en) | Pharmaceutical composition for promoting osteogenesis | |
DK605589D0 (en) | USE OF AMINOBENZOCYCLOALKANES OR ACID ADDITIONAL SALTS THEREOF FOR THE PREPARATION OF A PHARMACEUTICALS, THEREFORE PREPARED PREPARATION AND ITS USE | |
EP0453247A3 (en) | Anti-viral compounds | |
AU3302389A (en) | N-alkylamino derivatives of aromatic, tricyclic compounds in the treatment of drug-resistant protozoal infections | |
NO912382L (en) | PHARMACEUTICAL COMBINATION PREPARATIONS CONTAINING CEPHALOSPORIN AND XANTINE DERIVATIVES AND THEIR USE. | |
ES2195439T3 (en) | ANTHRACICLINE GLYCOSIDS. | |
NO933628L (en) | Procedure and composition for the treatment of Herpes infections | |
DK288989A (en) | CHOLE STAGE DERIVATIVES, THEIR PREPARATION AND USE AS MEDICINES |